1. There are two types There are two types embryonic stem cell research and stem cell research. Embryonic stem cell research requires an embryo to be sacrificed. So while there are those pushing for more of your dollars for stem cell research, ask them what kind? There are alternatives to embryonic stem cell research if you are willing to save a life. A team of South Korean scientists has grown pancreatic beta cells, which can treat diabetes, from stem cells taken from the umbilical cord blood of newborn babies....
Source • 2 hours ago •
2. Study challenges conventional wisdom about cancer cells The current thinking states that dividing cells cannot be differentiated (specialized in form and function); instead, only undifferentiated, immature cells divide. Jude investigators challenged conventional wisdom about the eye cancer retinoblastoma by using a mouse model that allowed them to study the tumors as they develop and grow. Retinoblastoma is a tumor that forms in the developing retina--the layer of nerves at the back of the eye that responds to light. Approximately half of the...
Source • 4 hours ago •
3. Stem Cells: Hope vs. Hype Much of their hope, they say, rides on the possibility that human embryonic stem cells may generate insulin-producing cells that could be used to reverse the disease. Five days later, embryonic stem cells are extracted from the resulting blastocyst - a sphere of about 150 cells - terminating the embryo. Embryonic stem cells used for research begin with in vitro fertilization: a human egg that is fertilized and begins to grow in a laboratory. All the approved lines, scientists worry, have...
Source • •
4. CLC bio joins $2.5M research project on HIV, bird flu, and other ... Professor at the Department of Molecular Biology at University of Aarhus iNANO center, J rgen Kjems states, Being part of this research project and collaborating with the top scientists from IT University of Copenhagen and CLC bio will provide us with innovative and valuable tools as well as input for new and ground-breaking research into RNA-based diseases. Professor at the Department of Molecular Biology at University of Aarhus iNANO center, J rgen Kjems states, Being part of this...
Source • PressReleaseNetwork.com (press release) •
5. Other resources could upstage corn Experts say it will be years before companies decide whether those sources can be commercially viable, but the research is well under way. While corn gets the headlines, companies are exploring a host of other potential fuel sources, including sorghum stubble, citrus peel, timber scraps and even landfill trash. Business 7-Day Archive Monday. Ottawa-based Iogen corp. has been producing ethanol from wheat, oat and barley straw for several years at its demonstration plant in Canada, and it...
Source • •
6. Growing Demand for Advanced Data Handling Tools Promotes Need for ... Growing Demand for Advanced Data Handling Tools Promotes Need for Bioinformatics in the European Drug Discovery Market DUBLIN, Ireland--(BUSINESS WIRE)--May 10, 2007 - Research and Markets (http://www.researchandmarkets.com/reports/c56490) announces the addition of new Frost & Sullivan report Opportunities for Bioinformatics in European Drug Discovery Markets to their offering. Growing Demand for Advanced Data Handling Tools Promotes Need for Bioinformatics in the European Drug Discovery...
Source • PharmaLive.com (press release),PA •
7. Strength in biotech Massachusetts is home to one of every 50 residents in the nation, but has one of every seven jobs in the biotech industry -- it is a biotech supercluster. Bay Staters are the most well educated in the country, we are home to the world's best teaching hospitals and hosts of venture capitalists, and our higher education institutions -- geared toward an innovation economy -- can ensure we have the well-trained workforce the industry requires. Bay Staters are the most well educated in the...
Source • •
8. Researchers and industry must collaborate: EI Organised by Enterprise Ireland's commercialisation unit, the 'Growth Through Technology' seminar saw venture capitalists, private investors and entrepreneurs coming face-to-face with people working in three key tech-related areas: informatics, industrial technologies and lifesciences & food. Ireland's first commercialisation conference, which was held on Wednesday, drew 250 delegates together to help develop stronger ties between industry and researchers. Organised by Enterprise Ireland's...
Source • ElectricNews.net,Ireland •
9. OAC aims for RM200m gross premium income this year Cryocord, the country's first internationally certified stem cell storage facility, is a medical biotechnology company specialising in cord blood banking and stem cell research. Cord blood is a vital source of stem cells which are now recognised as one of the promising medical treatments for over 85 different types of illnesses worldwide. OAC, with 12 branches nationwide and serving a customer base of more than half a million policy owners, offers various insurance products, ranging from...
Source • 5/26/2007 •
| ||||
| Archive [1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20] days ago | ||||